155 related articles for article (PubMed ID: 38608239)
21. Systems-level barriers to treatment in a cervical cancer prevention program in Kenya: Several observational studies.
Page CM; Ibrahim S; Park LP; Huchko MJ
PLoS One; 2020; 15(7):e0235264. PubMed ID: 32658921
[TBL] [Abstract][Full Text] [Related]
22. The Clinical and Economic Benefits of Co-Testing Versus Primary HPV Testing for Cervical Cancer Screening: A Modeling Analysis.
Felix JC; Lacey MJ; Miller JD; Lenhart GM; Spitzer M; Kulkarni R
J Womens Health (Larchmt); 2016 Jun; 25(6):606-16. PubMed ID: 27023044
[TBL] [Abstract][Full Text] [Related]
23. Impact of healthcare access and HIV testing on utilisation of cervical cancer screening among US women at high risk of HIV infection: cross-sectional analysis of 2016 BRFSS data.
Zhang D; Advani S; Huchko M; Braithwaite D
BMJ Open; 2020 Jan; 10(1):e031823. PubMed ID: 31911515
[TBL] [Abstract][Full Text] [Related]
24. Barriers to cervical cancer screening among middle-aged and older rural Appalachian women.
Studts CR; Tarasenko YN; Schoenberg NE
J Community Health; 2013 Jun; 38(3):500-12. PubMed ID: 23179390
[TBL] [Abstract][Full Text] [Related]
25. Non-use and inadequate use of cervical cancer screening among a representative sample of women in the United States.
Narcisse MR; McElfish PA; Hallgren E; Pierre-Joseph N; Felix HC
Front Public Health; 2024; 12():1321253. PubMed ID: 38711762
[TBL] [Abstract][Full Text] [Related]
26. Breast, Cervical, and Colorectal Cancer Screening Adherence: Effect of Low Body Mass Index in Women.
Charkhchi P; Schabath MB; Carlos RC
J Womens Health (Larchmt); 2020 Jul; 29(7):996-1006. PubMed ID: 31928405
[No Abstract] [Full Text] [Related]
27. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
28. Cervical cancer screening and acute care visits among Medicaid enrollees with mental and substance use disorders.
Abrams MT; Myers CS; Feldman SM; Boddie-Willis C; Park J; McMahon RP; Kelly DL
Psychiatr Serv; 2012 Aug; 63(8):815-22. PubMed ID: 22660581
[TBL] [Abstract][Full Text] [Related]
29. Persistent Disparities in Cervical Cancer Screening Uptake: Knowledge and Sociodemographic Determinants of Papanicolaou and Human Papillomavirus Testing Among Women in the United States.
Johnson NL; Head KJ; Scott SF; Zimet GD
Public Health Rep; 2020; 135(4):483-491. PubMed ID: 32516053
[TBL] [Abstract][Full Text] [Related]
30. Factors associated with cervical cancer screening among young unmarried Japanese women: results from an internet-based survey.
Kaneko N
BMC Womens Health; 2018 Jul; 18(1):132. PubMed ID: 30064505
[TBL] [Abstract][Full Text] [Related]
31. Health Service Accessibility and Risk in Cervical Cancer Prevention: Comparing Rural Versus Nonrural Residence in New Mexico.
McDonald YJ; Goldberg DW; Scarinci IC; Castle PE; Cuzick J; Robertson M; Wheeler CM
J Rural Health; 2017 Sep; 33(4):382-392. PubMed ID: 27557124
[TBL] [Abstract][Full Text] [Related]
32. Understanding Barriers to Cervical Cancer Screening in Women With Access to Care, Behavioral Risk Factor Surveillance System, 2014.
Crawford A; Benard V; King J; Thomas CC
Prev Chronic Dis; 2016 Nov; 13():E154. PubMed ID: 27831682
[TBL] [Abstract][Full Text] [Related]
33. Predictors of Cervical Cancer Screening Among Infrequently Screened Women Completing Human Papillomavirus Self-Collection: My Body My Test-1.
Lea CS; Perez-Heydrich C; Des Marais AC; Richman AR; Barclay L; Brewer NT; Smith JS
J Womens Health (Larchmt); 2019 Aug; 28(8):1094-1104. PubMed ID: 30874477
[No Abstract] [Full Text] [Related]
34. Perspectives on cervical cancer screening and prevention: challenges faced by providers and patients along the Texas-Mexico border.
Boom K; Lopez M; Daheri M; Gowen R; Milbourne A; Toscano P; Carey C; Guerra L; Carvajal JM; Marin E; Baker E; Fisher-Hoch S; Rodriguez AM; Burkalter N; Cavazos B; Gasca M; Cuellar MM; Robles E; Lopez E; Schmeler K
Perspect Public Health; 2019 Jul; 139(4):199-205. PubMed ID: 30117782
[TBL] [Abstract][Full Text] [Related]
35. Cervical Cancer Screening Barriers and Risk Factor Knowledge Among Uninsured Women.
Akinlotan M; Bolin JN; Helduser J; Ojinnaka C; Lichorad A; McClellan D
J Community Health; 2017 Aug; 42(4):770-778. PubMed ID: 28155005
[TBL] [Abstract][Full Text] [Related]
36. Perceived barriers to cervical cancer screening among refugee women after resettlement: A qualitative study.
Parajuli J; Horey D; Avgoulas MI
Contemp Nurse; 2020 Aug; 56(4):363-375. PubMed ID: 32794428
[No Abstract] [Full Text] [Related]
37. A population study of screening history and diagnostic outcomes of women with invasive cervical cancer.
Benard VB; Jackson JE; Greek A; Senkomago V; Huh WK; Thomas CC; Richardson LC
Cancer Med; 2021 Jun; 10(12):4127-4137. PubMed ID: 34018674
[TBL] [Abstract][Full Text] [Related]
38. Cervical cancer risk and impact of Pap-based screening in HIV-positive women on antiretroviral therapy in Johannesburg, South Africa.
Rohner E; Sengayi M; Goeieman B; Michelow P; Firnhaber C; Maskew M; Bohlius J
Int J Cancer; 2017 Aug; 141(3):488-496. PubMed ID: 28440019
[TBL] [Abstract][Full Text] [Related]
39. Racial and ethnic differences in cervical cancer screening barriers and intentions: The My Body My Test-3 HPV self-collection trial among under-screened, low-income women.
Zeno EE; Brewer NT; Spees LP; Des Marais AC; Sanusi BO; Hudgens MG; Jackson S; Barclay L; Wheeler SB; Smith JS
PLoS One; 2022; 17(10):e0274974. PubMed ID: 36227948
[TBL] [Abstract][Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
